Press Releases (Page 140)

Humber River Health ranks among top Ontario hospitals in National Surgical Quality Improvement Program

TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Humber River Health (Humber) is pleased to have ranked among the top five Ontario hospitals for every category of the American College of Surgeons’ (ACS) 2023 National Surgical Quality Improvement Program (NSQIP), an outcomes-based program that is used by hospitals around the world to measure and improve the quality of surgical care. Humber is the only hospital in the province to achieve... ❯❯❯

Stonebriar Facial and Oral Surgery to Open McKinney Location Sept. 27

MCKINNEY, Texas and FRISCO, Texas, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stonebriar Facial and Oral Surgery, an oral and maxillofacial surgery (OMS) practice in Frisco, Texas, will open a new location in McKinney at 2164 N. Lake Forest Dr., Ste. 712. The practice will begin treating patients there, starting Sept. 27. “We’ve been treating McKinney patients for over 20 years, and we’re happy to officially be full time members of... ❯❯❯

KFSHRC at the forefront of precision medicine and genomic therapies in Saudi Arabia and the region

RIYADH, Saudi Arabia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is integrating genomic profiling and pharmacogenomics into clinical practice. These enhancements transform patient care by offering more targeted, effective treatments for complex diseases, including cancer and rare genetic disorders. Dr. Salah Baz, Head of Genomic Medicine at KFSHRC, stated: “We are witnessing a new... ❯❯❯

Noom Appoints Rachel Mahoney as Chief Brand Officer

Executive Joins Noom Following Launch of New Product Pairing Powerful Behavior Change Program with Powerful Medications for Lasting Weight Loss NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, is pleased to announce the appointment of Rachel Mahoney as Chief Brand Officer. Reporting directly to... ❯❯❯

KFSHRC Drives Saudi Arabia’s Rise as Global Biotech Powerhouse

RIYADH, Saudi Arabia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is leading Saudi Arabia’s efforts to become a global biotechnology powerhouse by pioneering advancements in genomics, biomanufacturing, and sustainable healthcare practices. A key achievement for KFSHRC is the localization of CAR T-cell production, making it the first in Saudi Arabia to produce these therapeutic cells... ❯❯❯

KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations

RIYADH, Saudi Arabia, Sept. 16, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) leads healthcare innovation, leveraging AI-driven patient management, remote diagnostics, and robotic surgeries. It contributes to Saudi Vision 2030 and is projected to add up to $27 billion to the Kingdom’s medical sector by 2030. KFSHRC’s robotic surgery program has set new precision and patient care benchmarks. In... ❯❯❯

KFSHRC Deputy CEO Receives Global Innovative Healthcare & Impact Transformation Award at New York Summit

RIYADH, Saudi Arabia, Sept. 16, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) Deputy Chief Executive Officer Dr. Björn Zoéga has been awarded the prestigious 2024 C3 Global Innovative Healthcare & Impact Transformation Award. This award honors leaders who devise and implement innovative solutions to enhance patient outcomes, increase accessibility, and reduce global healthcare costs. It also... ❯❯❯

Allarity Therapeutics Announces Two Patients Now Exceeding One Year of Treatment with Stenoparib in Advanced Ovarian Cancer Trial

- Durable Clinical Benefit Observed Beyond a Year on Treatment in Heavily Pre-Treated Patients Boston (September 16, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that two patients enrolled in its Phase 2 clinical trial of stenoparib for advanced, recurrent ovarian cancer have now exceeded... ❯❯❯

Extendicare Announces September 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the... ❯❯❯

KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions

RIYADH, Saudi Arabia, Sept. 15, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is cementing its position as a global leader in healthcare, evidenced by remarkable growth in international patient admissions and ground-breaking medical achievements. In 2023, KFSHRC treated 451 medical tourism patients from countries including Kuwait, Bahrain, Oman, Qatar, the UAE, Canada, Egypt, India, Jordan,... ❯❯❯